In addition, in a study by Endo et al., urinary sCD163 was shown to be a reliable predictor of renal proliferative disease in patients with LN (AUC = 0.83–0.89; sens.: 83%; spec.: 86%) [102]. Here, CD163 is linked to lobular neoplasia.